Chain-of-thought monitorability could improve generative AI safety by assessing how models come to their conclusions and ...

Google’s DeepMind and OpenAI, which makes ChatGPT, say they both achieved a gold medal-level performance at this year's ...

Google DeepMind's drug discovery company, Isomorphic Labs, is gearing up to launch the human trials of its AI-designed drugs.

Isomorphic Labs is preparing to test AI-designed drugs in humans, marking a new phase in drug development with artificial ...

July 21 (Reuters) - Alphabet's (GOOGL.O) Google and OpenAI said their artificial-intelligence models won gold medals at a ...

Isomorphic Labs, the AI-powered drug company spun out of Google’s DeepMind, just announced that it’s “getting ready” to begin ...

The biotechnology sector is hailing a major milestone as Isomorphic Labs, a startup incubated by Google DeepMind, prepares to enter human trials with a drug candidate designed using artificial ...

Google DeepMind’s Gemini and OpenAI’s ChatGPT achieved gold medal-level scores at the 2025 International Mathematical ...

Neuralink achieved two brain transplants in a day, targeting 20 by year-end. CEO Elon Musk envisions healing paralysis and ...

OpenAI and Google's AI models achieved impressive results in a difficult math competition, but disputed how the other got ...

Researchers are urging developers to prioritize research into “chain-of-thought” processes, which provide a window into how ...

Google DeepMind subsidiary, Isomorphic Labs, has said it is ready to conduct human trials for drugs developed using its AlphaFold AI technology.